id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-5192-0014,FDA,FDA-2019-N-5192,"Microbiology Devices; Reclassification
of Human Immunodeficiency Virus
Serological Diagnostic and
Supplemental Tests and Human
Immunodeficiency Virus Nucleic Acid
Diagnostic and Supplemental Tests",Rule,Final Rule,2022-05-16T04:00:00Z,2022,5,2022-05-16T04:00:00Z,,2022-05-16T14:35:27Z,2022-10461,0,0,090000648507f151